HLA-C and neoplasm: This outcome could reflect a downregulation of immune checkpoints on malignant cells concomitant with a downregulation of MHC-related molecules on both the malignant cells and antigen-presenting cells within host immune compartments, possibly including tumor-infiltrating antigen-presenting cells.